>>Signaling Pathways>> Immunology/Inflammation>>D-(+)-Cellopentaose

D-(+)-Cellopentaose (Synonyms: β-D-Cellopentaose)

Catalog No.GC49792

D-(+)-Cellopentaose는 셀룰로오스의 penta oligosaccharide입니다.

Products are for research use only. Not for human use. We do not sell to patients.

D-(+)-Cellopentaose Chemical Structure

Cas No.: 2240-27-9

Size 가격 재고 수량
1 mg
US$77.00
재고 있음
5 mg
US$311.00
재고 있음
10 mg
US$467.00
재고 있음
25 mg
US$972.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

D-(+)-Cellopentaose is an oligosaccharide derived from cellulose.1 It has been used as a synthetic acceptor co-substrate to characterize the binding domains and enzyme kinetics of the E. coli pEtN transferase BcsG found in E. coli biofilms.2 D-(+)-Cellopentaose has also been used as a substrate for a synthetic receptor designed to solubilize polysaccharides for use in tissue engineering and biological applications.3

1.Wolfrom, M.L., and Dacons, J.C.The polymer-homologous series of oligosaccharides from celluloseJ. AM. Chem. Soc.74(21)5331-5333(1952) 2.Anderson, A.C., Burnett, A.J.N., Constable, S., et al.A mechanistic basis for phosphoethanolamine modification of the cellulose biofilm matrix in Escherichia coliBiochemistry60(47)3659-3669(2021) 3.Mooibroek, T.J., Casas-Solvas, J.M., Harniman, R.L., et al.A threading receptor for polysaccharidesNat. Chem.8(1)69-74(2016)

리뷰

Review for D-(+)-Cellopentaose

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-(+)-Cellopentaose

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.